logo

For the Inventor, By the Inventor

Hyderabad Telangana, India

Arabinda Chaudhuri

This inventor holds 11 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Council of Scientific and Industrial Research, Mayo Foundation for Medical Education and Research. Active years: 2001-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arabinda Chaudhuri. Retrieved from https://idiyas.com/inventor/arabinda-chaudhuri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 63.6

 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 143(Granted Patents)


Location History:

  • Ghaziabad, IN (2012)
  • Hyderabad, IN (2001 - 2017)
  • Andhra Pradesh, IN (2016 - 2019)
  • Telangna, IN (2020)

Company Filing History:

goldMedal11 out of 2,130 
 
Council of Scientific and Industrial Research
 patents
silverMedal1 out of 1,809 
 
Mayo Foundation for Medical Education and Research
 patents
where one patent can have more than one assignee

Years Active: 2001-2020

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 10611796 - Method for regressing pancreatic tumor by a liposomal formulation along with DNA vaccines (2020-04-07),
2. 10227589 - Method for inhibiting tumor growth through RNA-interference using liposomally associated CDC20 siRNA (2019-03-12),
3. 9840530 - Mannose-receptor selective lysinylated cationic amphiphiles and a process for preparation thereof (2017-12-12),
4. 9403869 - [object Object] (2016-08-02),
5. 8703824 - Cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof (2014-04-22),
6. 8278483 - Process for synthesis of glycomimicking cationic amphiphiles (2012-10-02),
7. 7297712 - Cationic amphiphiles for intracellular delivery of therapeutic molecules and its composition, process and method of treatment (2007-11-20),
8. 6541649 - Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules (2003-04-01),
9. 6503945 - Cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules (2003-01-07),
10. 6346516 - Cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules (2002-02-12),
11. 6333433 - Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkl group for intracellular delivery of biologically active molecules (2001-12-25),

Title: Innovations and Contributions of Arabinda Chaudhuri

Introduction

Arabinda Chaudhuri is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medical research, particularly in the development of innovative therapeutic methods for cancer treatment. With a total of 11 patents to his name, Chaudhuri's work has the potential to impact the lives of many patients suffering from various forms of cancer.

Latest Patents

Among his latest patents is a method for regressing pancreatic tumors using a liposomal formulation combined with DNA vaccines. This invention discloses a Plectin-1 receptor targeting novel cationic KTLLPTPK(SEQ ID NO: 1)-lipopeptide. The formulation includes at least two co-lipids, a therapeutic agent, and a pharmaceutically acceptable carrier. Additionally, it provides a method for regressing established pancreatic tumors by administering a therapeutically effective amount of the liposomal formulation along with targeted genetic immunization.

Another notable patent involves a method for inhibiting tumor growth through RNA interference using liposomally associated CDC20 siRNA. This patent describes liposomal compositions that contain guanidinylated cationic amphiphiles as the main lipid, along with cholesterol and other co-lipids. These compositions are designed to encapsulate or electrostatically complex therapeutic small interfering RNAs (siRNAs) against Cdc20, a key cell cycle regulator, which can inhibit solid tumor growth and melanoma tumor growth in mice.

Career Highlights

Chaudhuri has worked with esteemed organizations such as the Council of Scientific & Industrial Research and the Mayo Foundation for Medical Education and Research. His career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Chaudhuri has collaborated with notable colleagues, including Nalam Madhusudhana Rao and Rajkumar Banerjee. These collaborations have contributed to the success of his research endeavors and the development of his patented technologies.

Conclusion

Arabinda Chaudhuri's contributions to cancer research through his innovative patents highlight his role as a leading inventor in the field. His work not only showcases his expertise but also holds promise for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…